What is the role of systemic thrombolytic therapy for deep vein thrombosis (DVT)?

Updated: Aug 04, 2021
  • Author: Wanda L Rivera-Bou, MD, FAAEM, FACEP; Chief Editor: Erik D Schraga, MD  more...
  • Print


Systemic thrombolytic therapy is reserved for selected patients with extensive proximal DVT (eg, symptoms of less than 14 days’ duration, good functional status, and life expectancy exceeding 1 year) whose risk of bleeding is low to reduce postthrombotic morbidity if CDT is not available. [30]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!